Your browser doesn't support javascript.
loading
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
Sylla, M; Dolo, O; Maiga, A I; Traore, F T; Coulibaly, Y A; Togo, J; Fofana, D B; Dicko-Traore, F; Doumbia, S; Orsega, S; Diallo, S; Murphy, R L; Calvez, V; Marcelin, A G.
Afiliação
  • Sylla M; Department of Pediatrics, University Hospital Gabriel Toure, Bamako, Mali; Unit for Epidemiology and Molecular of HIV Drug Resistance, SEREFO/UCRC, FMOS, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali. Electronic address: dr_mame@yahoo.fr.
  • Dolo O; Unit for Epidemiology and Molecular of HIV Drug Resistance, SEREFO/UCRC, FMOS, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Maiga AI; Unit for Epidemiology and Molecular of HIV Drug Resistance, SEREFO/UCRC, FMOS, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Department of Medical Biology, University Hospital Gabriel Toure, Bamako, Mali.
  • Traore FT; Unit for Epidemiology and Molecular of HIV Drug Resistance, SEREFO/UCRC, FMOS, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Coulibaly YA; Department of Pediatrics, University Hospital Gabriel Toure, Bamako, Mali.
  • Togo J; Unit for Epidemiology and Molecular of HIV Drug Resistance, SEREFO/UCRC, FMOS, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Fofana DB; FMOS, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Dicko-Traore F; Department of Pediatrics, University Hospital Gabriel Toure, Bamako, Mali.
  • Doumbia S; University Clinical Research Center, UCRC, Bamako, Mali.
  • Orsega S; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Diallo S; University Clinical Research Center, UCRC, Bamako, Mali.
  • Murphy RL; Northwestern University, Chicago, IL, USA.
  • Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de virologie, Paris, France.
  • Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de virologie, Paris, France.
Arch Pediatr ; 26(5): 254-258, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31307909
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Farmacorresistência Viral Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Farmacorresistência Viral Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article